Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
80.5M
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$1.77B
-
Value change
-
-$27.1M
-
Put/Call ratio
-
1.11
-
Number of buys
-
82
-
Number of sells
-
-100
-
Price
-
$22.00
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2021
234 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2021.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.5M shares
of 106M outstanding shares and own 76.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.6M shares), VANGUARD GROUP INC (12M shares), RENAISSANCE TECHNOLOGIES LLC (8.52M shares), INGALLS & SNYDER LLC (7.07M shares), FEDERATED HERMES, INC. (5.08M shares), STATE STREET CORP (3.28M shares), DIMENSIONAL FUND ADVISORS LP (2.79M shares), GEODE CAPITAL MANAGEMENT, LLC (1.81M shares), Parallel Advisors, LLC (1.67M shares), and Invesco Ltd. (1.27M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.